Ethos sets fiscal 2026 revenue target between $727 million and $731 million, launches $100 million buyback
Fiscal year 2026 revenue guidance is in focus for Ethos, with the company projecting a range of $727 million to $731 million. Alongside that outlook, Ethos launched a $100 million share repurchase program. The two…
Key takeaways
- Ethos set its fiscal 2026 revenue guidance at a range of $727 million to $731 million, with a midpoint of $729 million.
- The guidance band spans just $4 million between floor and ceiling, making it a relatively narrow corridor.
- Ethos launched a $100 million share repurchase program alongside the revenue guidance.
- The buyback authorization gives Ethos the right, but not the obligation, to buy back up to $100 million of its own shares on the open market.
- Key items to watch are the pace of buyback execution and the actual fiscal 2026 revenue result against the guided range.
Fiscal year 2026 revenue guidance is in focus for Ethos, with the company projecting a range of $727 million to $731 million. Alongside that outlook, Ethos launched a $100 million share repurchase program. The two announcements, taken together, draw the map for investors watching the name.
The revenue guidance
The range Ethos has set runs $727 million at the low end and $731 million at the high end. Four million dollars separate floor from ceiling, making this a relatively narrow corridor to work with. A tight guidance band can reflect management's visibility into near-term results, though it also leaves limited room between a beat and a miss relative to the midpoint.
That midpoint falls at $729 million. The actual fiscal year revenue print, when it arrives, will confirm whether the company performed inside the corridor, came in short of the $727 million floor, or cleared the $731 million ceiling. Each outcome carries a different weight for the setup.
The $100 million repurchase program
Ethos paired the guidance with the announcement of a $100 million share repurchase program. Buyback authorizations of this type give a company the right to buy its own shares on the open market up to a set dollar limit. The authorization does not obligate the company to deploy the full amount. Execution against the program is a separate decision from announcing it.
For anyone watching the tape, the size of the authorization matters less than the pace at which the company moves on it. A $100 million program deployed quickly reads differently than the same authorization left largely untouched.
What to watch
The two data points that matter from here are the pace of execution on the $100 million buyback and the actual fiscal year 2026 revenue result against the $727 million to $731 million range. Any revision to the guidance corridor before results arrive would become its own catalyst. Until then, the floor and ceiling of that range are the numbers the tape will hold.